The global antifungal drugs market size reached US$ 15.1 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 20.1 Billion by 2032, exhibiting a growth rate (CAGR) of 3.23% during 2023-2032.
Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.
Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
2. What is the expected growth rate of the global antifungal drugs market during 2024-2032?
3. What has been the impact of COVID-19 on the global antifungal drugs market?
4. What are the key factors driving the global antifungal drugs market?
5. What is the breakup of the global antifungal drugs market based on the drug class?
6. What is the breakup of the global antifungal drugs market based on the indication?
7. What are the key regions in the global antifungal drugs market?
8. Who are the key players/companies in the global antifungal drugs market?
Antifungal drugs, or antimycotic drugs, refer to the pharmaceutical medicines used for the treatment of fungal infections on skin, hair and nails. Some of the commonly used antifungal drugs include polyenes, azoles and allylamines. They specifically neutralize fungal agents and dermatophytes, such as candida and tapeworms, and aid in the treatment of athlete’s foot, ringworm, aspergillosis, candidiasis and fungal meningitis. These drugs are commonly available in over the counter (OTC) capsule, gel, liquid and pill variants or intravenous solutions that are injected directly into the bloodstream to minimize and prevent fungal infection.
Antifungal Drugs Market Trends:
The increasing prevalence of fungal and nosocomial infections is one of the key factors creating a positive outlook for the market growth. Antifungal drugs are effective against both systemic and superficial infections that are acquired from exposure to contaminated surfaces in hospitals or humid conditions. Moreover, the convenient availability of OTC drugs in both urban and rural areas is providing a thrust to the market growth. With the rising health consciousness among the masses, consumers are increasingly opting for OTC therapeutics to timely treat minor infections.Additionally, various product innovations, such as the development of synthetic and semi-synthetic azole-based compounds for the treatment of invasive fungal infections, are acting as other growth-inducing factors. Pharmaceutical manufacturers are also investing extensively in the research and development (R&D) of novel therapeutics in the form of sprays, creams, tablets and injections with enhanced efficacy. Other factors, including significant growth in the pharmaceutical industry, along with the implementation of favorable government policies promoting public health, are anticipated to drive the market toward growth.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global antifungal drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on drug class and indication.Breakup by Drug Class:
- Azoles
- Voriconazole (Vfend)
- Posaconazole (Noxafil)
- Clotrimazole (Canesten)
- Isavuconazole (CRESEMBA)
- Others
- Echinocandins
- Caspofungin (Cancidas)
- Micafungin (Mycamine/ Funguard)
- Others
- Polyenes
- Amphotericin (AmBisome)
- Others
- Allylamines
- Terbinafine (Lamisil)
- Others
- Others
Breakup by Indication:
- Dermatophytosis
- Aspergillosis
- Candidiasis
- Invasive Candidiasis
- Vulvovaginal Candidiasis (VVC)
- Mouth/Throat/Esophageal Candidiasis
- Others
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arcadia Consumer Healthcare Inc., Astellas Pharma Inc., Bayer AG, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi S.A. and Scynexis Inc.Key Questions Answered in This Report
1. What was the size of the global antifungal drugs market in 2023?2. What is the expected growth rate of the global antifungal drugs market during 2024-2032?
3. What has been the impact of COVID-19 on the global antifungal drugs market?
4. What are the key factors driving the global antifungal drugs market?
5. What is the breakup of the global antifungal drugs market based on the drug class?
6. What is the breakup of the global antifungal drugs market based on the indication?
7. What are the key regions in the global antifungal drugs market?
8. Who are the key players/companies in the global antifungal drugs market?
Table of Contents
1 Preface3 Executive Summary10 Value Chain Analysis12 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Antifungal Drugs Market
6 Market Breakup by Drug Class
7 Market Breakup by Indication
8 Market Breakup by Region
9 SWOT Analysis
11 Porters Five Forces Analysis
13 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Abbott Laboratories
- Arcadia Consumer Healthcare Inc.
- Astellas Pharma Inc.
- Bayer AG
- GlaxoSmithKline Plc
- Merck & Co. Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Sanofi S.A.
- Scynexis Inc.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 147 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 15.1 Billion |
| Forecasted Market Value ( USD | $ 20.1 Billion |
| Compound Annual Growth Rate | 3.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
